PT  - JOURNAL ARTICLE
AU  - Ross M. Kedl
AU  - Elena Hsieh
AU  - Thomas E. Morrison
AU  - Gabriela Samayoa-Reyes
AU  - Siobhan Flaherty
AU  - Conner L. Jackson
AU  - Rosemary Rochford
TI  - Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity
AID  - 10.1101/2022.04.28.22274443
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.28.22274443
4099  - http://medrxiv.org/content/early/2022/05/01/2022.04.28.22274443.short
4100  - http://medrxiv.org/content/early/2022/05/01/2022.04.28.22274443.full
AB  - Despite the obvious knowledge that infectious particles can be shared through respiration, whether other constituents of the nasal/oral fluids can be passed between hosts has surprisingly never even been postulated, let alone investigated. The circumstances of the present pandemic facilitated a unique opportunity to fully examine this provocative idea. The data we show provides evidence for a new mechanism by which herd immunity may be manifested, the aerosol transfer of antibodies between immune and non-immune hosts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Acquisition of clinical samples was performed in accordance with approval from the Institutional Review Board at the University of Colorado Anschutz Medical campus, protocol #20-1279.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll materials, data, and associated protocols will be available to readers upon request and without undue qualifications